Matthew Azzara
Head, Oncology Global Portfolio Management
EMD Serono
Greater Boston, United States
About me
My organisation
We aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer.
We are imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs.
EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. Our global roots go back more than 350 years. Today, we have approximately 1,100 employees around the US with commercial, clinical and research operations in Massachusetts.
Speaker sessions (4)
Wednesday, 13 November 2024
10:30 - 11:00
PANEL DISCUSSION: Navigating risks in biotech
Strategies for Success
Thursday, 14 November 2024
14:00 - 14:30
KEYNOTE: Risk management for portfolio optimization
- ASSESSING PORTFOLIO RISK
Friday, 15 November 2024
10:00 - 10:30
PANEL DISCUSSION: PPM tools in managing complex projects
- GOVERNANCE AND RISK MANAGEMENT
12:00 - 12:30
PANEL DISCUSSION: Leveraging technologies for improved decision making
- DEEP DIVE INTO ARTIFICIAL INTELLIGENCE (AI), MACHINE LEARNING, AND PREDICTIVE ANALYTICS TO IMPROVE DECISION-MAKING